Redx Pharma PLC (LON:REDX), the drug discovery and development company focused on cancer and fibrosis, said non-executive chairman Iain Ross is stepping down from his role as a director.
Peter Presland, currently a non-executive director of Redx, has been appointed as interim chairman with immediate effect.
A search is underway for a permanent replacement.
"Iain has been the lynchpin in the turnaround of Redx and we are very grateful for his innumerable contributions as chairman over the last four years,” said Lisa Anso, the chief executive of Redx.